Cwm, LLC Immunic, Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Cwm, LLC holds 8,642 shares of IMUX stock, worth $6,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,642
Previous 8,642
-0.0%
Holding current value
$6,049
Previous $6,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding IMUX
# of Institutions
64Shares Held
50.1MCall Options Held
13.2KPut Options Held
60.6K-
Abrdn PLC8.24MShares$5.77 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$5.36 Million0.21% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$5.11 Million0.4% of portfolio
-
Avidity Partners Management LP Dallas, TX5.62MShares$3.93 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$2.89 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $21.4M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...